Pittenger & Anderson’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Pittenger & Anderson's AZN Position: Q3 2026 in Review
Pittenger & Anderson increased its AstraZeneca (AZN) stake by 10% in Q3 2026, buying an estimated $540K and bringing the position to 35,699 shares worth $5.76M. The position accounts for 0.21% of the portfolio, ranked #99.
Pittenger & Anderson first reported a position in AZN in Q2 2013 and has held it in 26 quarters since. The position peaked at $6.4M in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Pittenger & Anderson held 35,699 shares of AstraZeneca worth $5.76M as of Q3 2026.
- Pittenger & Anderson bought 3,240 AstraZeneca shares in Q3 2026, an estimated $540K.
- AstraZeneca made up 0.21% of Pittenger & Anderson's portfolio in Q3 2026, its #99 holding.
- Pittenger & Anderson first reported a position in AstraZeneca in Q2 2013 and has held it in 26 quarters since.
- Pittenger & Anderson's AstraZeneca position peaked at $6.4M in Q1 2026.
- 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Pittenger & Anderson's 13F filing for Q3 2026, filed 2 Nov 2026.